关于双活性肝脏和血液阶段抗等离子体的机制性见解
Mukul Rawat1,2, Nonlawat Boonyalai1, Cindy Smidt2
1Division of Biological Chemistry and Drug Discovery, Wellcome Centre for Anti-Infectives Research, University of Dundee, Dundee, DD1 5EH, UK.
bioRxiv : the preprint server for biology
|August 13, 2025
概括
研究人员通过进化寄生虫耐药性来确定新的抗疟疾药物点. 这种方法验证了乙CoA合成酶,异黄素tRNA合成酶和蛋白激酶G作为新型抗疟疾化合物的标,从而推进了疟疾治疗策略.
科学领域:
- 药物的发现和开发.
- 寄生虫学的寄生虫学
- 分子生物学分子生物学
背景情况:
- 针对肝脏和血液阶段的新型抗疟疾药物提供了预防和治疗潜力.
- 从表型选中识别药物标仍然是抗疟疾研究的一个重大挑战.
研究的目的:
- 为了确定具有双肝和无性血液阶段活性的抗疟疾化合物的药物标.
- 研究Tres Cantos抗疟剂组 (TCAMS) 中化合物的作用机制.
主要方法:
- 使用体外耐药性演变来识别对9种TCAMS化合物产生耐药性的突变.
- 使用CRISPR编辑和体外活性测试与重组蛋白用于目标验证.
- 应用抗疟疾耐药条码测序测定 (AReBar) 用于交叉耐药性评估.
主要成果:
- 引起对四种化合物的耐药性,识别了乙CoA合成酶 (AcAS),细胞质异质核素tRNA合成酶 (cIRS) 和蛋白质激酶G (PKG) 的突变.
- 已经验证了TCMDC-125075 (AcAS),TCMDC-124602 (cIRS) 和TCMDC-141334/TCDMC-140674 (PKG) 作为目标.
- 在PKG的守门者残留物中观察到T618I突变,这表明直接的活性部位相互作用,进一步得到分子对接的支持.
- 对五种耐火化合物的AReBar分析没有得到验证的结果,这表明了新的作用机制.
结论:
- 成功确定并验证了AcAS,cIRS和PKG作为特定抗疟疾化合物的标.
- 证明了体外耐药性演变和AReBar对于抗疟疾药物标识的有用性.
- 突出了五种化合物作为潜在的候选人进行进一步的探索,由于可能的新的作用机制.
更多相关视频
08:20In Vitro Assay of Plasmodium-Infected Red Blood Cell Killing by Cytotoxic Lymphocytes
Published on: August 17, 2022
2.2K
08:46Myeloid Cell Isolation from Mouse Skin and Draining Lymph Node Following Intradermal Immunization with Live Attenuated Plasmodium Sporozoites
Published on: May 18, 2016
17.6K
相关概念视频
01:07Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
80
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
80
00:58Symbiosis
30.7K
Symbiotic relationships are long-term, close interactions between individuals of different species that affect the distribution and abundance of those species. When a relationship is beneficial to both species, this is called mutualism. When the relationship is beneficial to one species but neither beneficial nor harmful to the other species, this is called commensalism. When one organism is harmed to benefit another, the relationship is known as parasitism. These types of relationships often...
30.7K